Aardvark Therapeutics Inc. Common Stock (AARD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aardvark Therapeutics Inc...

    NASDAQ: AARD · Real-Time Price · USD
    16.98
    0.90 (5.60%)
    At close: Oct 06, 2025, 1:46 PM

    Aardvark Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 92K 140K 137K 162K 101K 53K 51K 26K
    Gross Profit
    		 -92K -140K -137K -162K -101K -53K -51K -26K
    Operating Income
    		 -40.86M -31.08M -22.79M -15.57M -12.2M -6.12M -3.95M -1.72M
    Interest Income
    		 2.89M 3.49M 2.41M 1.81M 950K 356K 253K 135K
    Pretax Income
    		 -36.64M -27.72M -20.59M -13.85M -11.78M -6.33M -4.15M -2.11M
    Net Income
    		 -36.64M -27.72M -20.59M -13.85M -11.78M -6.33M -4.15M -2.11M
    Selling & General & Admin
    		 7.83M 7.16M 5.3M 4.44M 3.95M 1.92M 1.06M 538K
    Research & Development
    		 33.03M 23.91M 17.36M 10.84M 7.74M 3.71M 2.5M 964K
    Other Expenses
    		 n/a 14K 117K 288K 505K 491K 388K 217K
    Operating Expenses
    		 40.86M 31.08M 22.79M 15.57M 12.2M 6.12M 3.95M 1.72M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 40.86M 31.08M 22.79M 15.57M 12.2M 6.12M 3.95M 1.72M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 21.69M 13.19M 12.91M 12.91M 2.56M 12.91M 9.73M 9.73M
    Shares Outstanding (Diluted)
    		 21.69M 13.19M 12.91M 12.91M 2.56M 12.91M 9.73M 9.73M
    EPS (Basic)
    		 -2.37 -3.84 -3.3 -2.83 -2.73 -0.6 -0.43 -0.22
    EPS (Diluted)
    		 -2.37 -3.84 -3.3 -2.83 -2.73 -0.6 -0.43 -0.22
    EBITDA
    		 -40.77M -30.95M -22.65M -15.21M -11.69M -5.66M -3.49M -1.48M
    EBIT
    		 -38.22M -29.92M -22.79M -15.38M -11.79M -5.71M -3.54M -1.5M
    Depreciation & Amortization
    		 100K 148K 145K 162K 101K 53K 51K 26K

    Add to Watchlist